Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia
- PMID: 24650500
- PMCID: PMC4024332
- DOI: 10.1016/j.conb.2013.11.003
Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia
Abstract
Schizophrenia is a disorder of cognitive neurodevelopment. At least some of the core cognitive deficits of the illness appear to be the product of impaired gamma frequency oscillations which depend, in part, on the inhibitory actions of a subpopulation of cortical GABA neurons that express the calcium binding protein parvalbumin (PV). Recent studies have revealed new facets of the development of PV neurons in primate neocortex and of the nature of their molecular alterations in individuals with schizophrenia. Other recent studies in model systems provide insight into how these alterations may arise in the course of cortical circuitry development.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Figures
References
-
- Guidotti A, Auta J, Davis JM, Gerevini VD, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder. Arch Gen Psychiatry. 2000;57:1061–1069. - PubMed
-
-
Rowland LM, Kontson K, West J, Edden RA, Zhu H, Wijtenburg SA, Holcomb HH, Barker PB. In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull. 2013;39:1096–1104. This study represents an important addition to the literature on in vivo measures of cortical GABA levels in subjects with schizophrenia and helps explain why current findings are discrepant.
-
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
